Your browser doesn't support javascript.
loading
Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.
Nakajima, Akio; Masaki, Yasufumi; Nakamura, Takuji; Kawanami, Takafumi; Ishigaki, Yasuhito; Takegami, Tsutomu; Kawano, Mitsuhiro; Yamada, Kazunori; Tsukamoto, Norifumi; Matsui, Shoko; Saeki, Takako; Okazaki, Kazuichi; Kamisawa, Terumi; Miyashita, Taiichiro; Yakushijin, Yoshihiro; Fujikawa, Keita; Yamamoto, Motohisa; Hamano, Hideaki; Origuchi, Tomoki; Hirata, Shintaro; Tsuboi, Hiroto; Sumida, Takayuki; Morimoto, Hisanori; Sato, Tomomi; Iwao, Haruka; Miki, Miyuki; Sakai, Tomoyuki; Fujita, Yoshimasa; Tanaka, Masao; Fukushima, Toshihiro; Okazaki, Toshiro; Umehara, Hisanori.
Affiliation
  • Nakajima A; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Masaki Y; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Nakamura T; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Kawanami T; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Ishigaki Y; Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Takegami T; Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Kawano M; Division of Rheumatology, Department of Internal Medicine, Kanazawa University Hospital, Ishikawa 920-8641, Japan.
  • Yamada K; Division of Rheumatology, Department of Internal Medicine, Kanazawa University Hospital, Ishikawa 920-8641, Japan.
  • Tsukamoto N; Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan.
  • Matsui S; Health Administration Center University of Toyama, Toyama 930-0194, Japan.
  • Saeki T; Department of Internal Medicine, Nagaoka Red Cross Hospital, Niigata 940-2085, Japan.
  • Okazaki K; Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Osaka 573-1191, Japan.
  • Kamisawa T; Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677, Japan.
  • Miyashita T; Department of Rheumatology, National Hospital Organization Nagasaki Medical center, Nagasaki 380-8582, Japan.
  • Yakushijin Y; Department of Clinical Oncology, Ehime Graduate School of Medicine, Ehime 791-0295, Japan.
  • Fujikawa K; Department of Rheumatology, Japan Community Healthcare Organization, Isahaya General Hospital, Nagasaki 854-8501, Japan.
  • Yamamoto M; Department of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Hokkaido 060-8543, Japan.
  • Hamano H; Medical Informatics Division and Department of Internal Medicine, Gastroenterology, Shinshu University School Hospital, Nagano 390-8621, Japan.
  • Origuchi T; First Department of Internal Medicine, Department of Immunology and Rheumatology, Nagasaki Graduate School of Health Sciences, Nagasaki 852-8520, Japan.
  • Hirata S; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Fukuoka 807-8555, Japan.
  • Tsuboi H; Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan.
  • Sumida T; Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan.
  • Morimoto H; Division of Nephrology, Mitoyo General Hospital, Kagawa 769-1695, Japan.
  • Sato T; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Iwao H; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Miki M; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Sakai T; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Fujita Y; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Tanaka M; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Fukushima T; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Okazaki T; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan.
  • Umehara H; Hematology and Immunology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan; Department of Clinical Immunology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto 606-8501, Japan.
PLoS One ; 10(5): e0126582, 2015.
Article in En | MEDLINE | ID: mdl-25973893
ABSTRACT

BACKGROUND:

IgG4-related disease (IgG4-RD) is a new clinical entity of unknown etiology characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. Although aberrancies in acquired immune system functions, including increases in Th2 and Treg cytokines observed in patients with IgG4-RD, its true etiology remains unclear. To investigate the pathogenesis of IgG4-RD, this study compared the expression of genes related to innate immunity in patients with IgG4-RD and healthy controls. MATERIALS AND

METHODS:

Peripheral blood mononuclear cells (PBMCs) were obtained from patients with IgG4-RD before and after steroid therapy and from healthy controls. Total RNA was extracted and DNA microarray analysis was performed in two IgG4-RD patients to screen for genes showing changes in expression. Candidate genes were validated by real-time RT-PCR in 27 patients with IgG4-RD and 13 healthy controls.

RESULTS:

DNA microarray analysis identified 21 genes that showed a greater than 3-fold difference in expression between IgG4-RD patients and healthy controls and 30 genes that showed a greater than 3-fold change in IgG4-RD patients following steroid therapy. Candidate genes related to innate immunity, including those encoding Charcot-Leyden crystal protein (CLC), membrane-spanning 4-domain subfamily A member 3 (MS4A3), defensin alpha (DEFA) 3 and 4, and interleukin-8 receptors (IL8R), were validated by real-time RT-PCR. Expression of all genes was significantly lower in IgG4-RD patients than in healthy controls. Steroid therapy significantly increased the expression of DEFA3, DEFA4 and MS4A3, but had no effect on the expression of CLC, IL8RA and IL8RB.

CONCLUSIONS:

The expression of genes related to allergy or innate immunity, including CLC, MS4A3, DEFA3, DEFA4, IL8RA and IL8RB, was lower in PBMCs from patients with IgG4-RD than from healthy controls. Although there is the limitation in the number of patients applied in DNA microarray, impaired expression of genes related to innate immunity may be involved in the pathogenesis of IgG4-RD as well as in abnormalities of acquired immunity.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Leukocytes, Mononuclear Type of study: Observational_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Leukocytes, Mononuclear Type of study: Observational_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2015 Document type: Article Affiliation country: